title: Smoking cessation treatment among office-based buprenorphine treatment patients.
abstract: Opioid-dependent patients smoke at high rates, and office-based buprenorphine treatment provides an opportunity to offer cessation treatment. We examined tobacco use and smoking cessation treatment patterns among office-based buprenorphine treatment patients. We reviewed records of 319 patients treated with buprenorphine from 2005 to 2010. We examined smoking status, cessation medication prescriptions, and factors associated with receipt of cessation prescriptions. Mean age was 43.9 years; most were men (74.2%) and Hispanic (70.9%). At buprenorphine initiation, 21.9% had no documentation of smoking status, while 67.4% were current, 10% former, and 0.9% never smokers. Of current smokers, 16.8% received smoking cessation prescriptions. Patients retained (vs. not retained) in buprenorphine treatment were more likely to receive smoking cessation medications (26.3% vs. 11.2%, p<0.005). We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.
authors.affiliation: Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10467, USA; Department of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, 10467, USA. Electronic address: snahvi@montefiore.org.
authors.forename: Shadi
authors.initials: S
authors.lastname: Nahvi
authors.affiliation: Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10467, USA.
authors.forename: Oni
authors.initials: O
authors.lastname: Blackstock
authors.affiliation: Sophie Davis School of Biomedical Education, City College of New York, New York, NY, 10031, USA.
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Sohler
authors.affiliation: Howard University College of Medicine, Washington, DC, 20059, USA.
authors.forename: Devin
authors.initials: D
authors.lastname: Thompson
authors.affiliation: Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10467, USA.
authors.forename: Chinazo O
authors.initials: CO
authors.lastname: Cunningham
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D058850:Opiate Substitution Treatment / Q000379:methods; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D010349:Patient Compliance; D015995:Prevalence; D012189:Retrospective Studies; D012907:Smoking / Q000453:epidemiology; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention
chemical_list: D002047:Buprenorphine
keywords: Buprenorphine; Office-based treatment; Opioid; Smoking cessation; Tobacco smoking